Literature DB >> 15477387

Identification of novel Myc target genes with a potential role in lymphomagenesis.

Dragan Marinkovic1, Tatjana Marinkovic, Eniko Kokai, Thomas Barth, Peter Möller, Thomas Wirth.   

Abstract

The c-Myc transcription factor regulates a wide set of genes involved in processes such as proliferation, differentiation and apoptosis. Therefore, altered expression of Myc leads to deregulation of a large number of target genes and, as a consequence, to tumorigenesis. For understanding Myc-induced transformation, identification of these target genes is essential. In this study, we searched for Myc target genes involved in lymphomagenesis using different mouse T and B cell lymphoma cell lines transformed by a conditional Myc-allele. Target genes obtained by microarray experiments were further subjected to a kinetic analysis of mRNA expression upon Myc inactivation/reactivation, bioinformatic examination of Myc binding sites and chromatin immunoprecipitation. This approach allowed us to define targets whose activation is a direct consequence of Myc binding. Among the 38 novel Myc targets, we identified several genes implicated in the tumor development. These genes are not only relevant for mouse lymphomas because we observed their upregulation in human lymphomas as well. Our findings further the understanding of Myc-induced lymphomagenesis and help toward developing more efficient antitumor strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477387      PMCID: PMC524288          DOI: 10.1093/nar/gkh877

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  69 in total

Review 1.  Control of c-myc regulation in normal and neoplastic cells.

Authors:  C A Spencer; M Groudine
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

Review 2.  Myc and Max function as a nucleoprotein complex.

Authors:  E M Blackwood; L Kretzner; R N Eisenman
Journal:  Curr Opin Genet Dev       Date:  1992-04       Impact factor: 5.578

3.  Max: functional domains and interaction with c-Myc.

Authors:  G J Kato; W M Lee; L L Chen; C V Dang
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

4.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

5.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

Review 6.  The role of iron in cell cycle progression and the proliferation of neoplastic cells.

Authors:  Nghia T V Le; Des R Richardson
Journal:  Biochim Biophys Acta       Date:  2002-10-02

7.  Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.

Authors:  M Eilers; D Picard; K R Yamamoto; J M Bishop
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

8.  Centrosomal proteins CG-NAP and kendrin provide microtubule nucleation sites by anchoring gamma-tubulin ring complex.

Authors:  Mikiko Takahashi; Akiko Yamagiwa; Tamako Nishimura; Hideyuki Mukai; Yoshitaka Ono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

9.  Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas.

Authors:  Y Shi; J M Glynn; L J Guilbert; T G Cotter; R P Bissonnette; D R Green
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

10.  Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.

Authors:  G C Prendergast; E B Ziff
Journal:  Science       Date:  1991-01-11       Impact factor: 47.728

View more
  19 in total

1.  MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.

Authors:  Dean W Felsher
Journal:  Genes Cancer       Date:  2010-06

2.  NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.

Authors:  Teresa Palomero; Wei Keat Lim; Duncan T Odom; Maria Luisa Sulis; Pedro J Real; Adam Margolin; Kelly C Barnes; Jennifer O'Neil; Donna Neuberg; Andrew P Weng; Jon C Aster; Francois Sigaux; Jean Soulier; A Thomas Look; Richard A Young; Andrea Califano; Adolfo A Ferrando
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

3.  PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.

Authors:  Ashley Pandolfi; Robert F Stanley; Yiting Yu; Boris Bartholdy; Gopichand Pendurti; Kira Gritsman; Jacqueline Boultwood; Jonathan Chernoff; Amit Verma; Ulrich Steidl
Journal:  Blood       Date:  2015-07-13       Impact factor: 22.113

4.  miR-451 limits CD4+ T cell proliferative responses to infection in mice.

Authors:  Lesley M Chapman; Sara K Ture; David J Field; Craig N Morrell
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

5.  A unified 35-gene signature for both subtype classification and survival prediction in diffuse large B-cell lymphomas.

Authors:  Yu-Dong Cai; Tao Huang; Kai-Yan Feng; Lele Hu; Lu Xie
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

6.  Prdx1 deficiency in mice promotes tissue specific loss of heterozygosity mediated by deficiency in DNA repair and increased oxidative stress.

Authors:  Vamsi Rani; Carola A Neumann; Changshun Shao; Jay A Tischfield
Journal:  Mutat Res       Date:  2012-05-11       Impact factor: 2.433

7.  Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.

Authors:  Marie-Eve Beaulieu; Toni Jauset; Daniel Massó-Vallés; Sandra Martínez-Martín; Peter Rahl; Loïka Maltais; Mariano F Zacarias-Fluck; Sílvia Casacuberta-Serra; Erika Serrano Del Pozo; Christopher Fiore; Laia Foradada; Virginia Castillo Cano; Meritxell Sánchez-Hervás; Matthew Guenther; Eduardo Romero Sanz; Marta Oteo; Cynthia Tremblay; Génesis Martín; Danny Letourneau; Martin Montagne; Miguel Ángel Morcillo Alonso; Jonathan R Whitfield; Pierre Lavigne; Laura Soucek
Journal:  Sci Transl Med       Date:  2019-03-20       Impact factor: 17.956

Review 8.  Targeting RNA polymerase I to treat MYC-driven cancer.

Authors:  G Poortinga; L M Quinn; R D Hannan
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

9.  A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response.

Authors:  Sanjay Chandriani; Eirik Frengen; Victoria H Cowling; Sarah A Pendergrass; Charles M Perou; Michael L Whitfield; Michael D Cole
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

10.  Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib.

Authors:  Petra Grbčić; Dora Fučkar Čupić; Tania Gamberi; Sandra Kraljević Pavelić; Mirela Sedić
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.